BIZZARI JEAN-PIERRE — SEC Form 4 filings

SEC reporting owner CIK 1630914. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-17.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-06-14 to 2026-06-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ADC Therapeutics SA (ADCT)Director51 leg · 6,995 sh · $20,2165
Aprea Therapeutics, Inc. (APRE)Director24

Form 4 filings — BIZZARI JEAN-PIERRE

FiledFormIssuerReported transactionsSource
2026-06-174Aprea Therapeutics, Inc. (APRE)Grant/award (A): 3,135 @ $0 · Grant/award (A): 12,555 (derivative) @ $0EDGAR
2026-06-034ADC Therapeutics SA (ADCT)Grant/award (A): 45,000 @ $0 · Tax withholding (F): 12,600 @ $3.08EDGAR
2025-06-174ADC Therapeutics SA (ADCT)Tax withholding (F): 12,600 @ $3.58EDGAR
2025-06-094Aprea Therapeutics, Inc. (APRE)Grant/award (A): 1,045 @ $0 · Grant/award (A): 4,185 (derivative) @ $0EDGAR
2025-06-054ADC Therapeutics SA (ADCT)Grant/award (A): 40,000 @ $0EDGAR
2024-06-184ADC Therapeutics SA (ADCT)Sale (S): 6,995 @ $2.89EDGAR
2024-06-144ADC Therapeutics SA (ADCT)Grant/award (A): 40,000 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1630914 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →